GQ2-55305-93262
3 vaccinations
1 coded response
8 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 61-65
- ZIP prefix
- 040 / ME
- Registered
- 2021-12-17
- Relationship
- Adult relative or friend
- Guardian
- DP3-23467-59387
- Race
- N/A
- Ethnicity
- N/A
Timeline
-
2021-03-17
Dose 1 — Moderna
-
2021-04-14
Dose 2 — Moderna
-
2021-12-09
Dose 3 — Moderna
-
2021-12-17
Registered in v-safe
-
2021-12-17
Survey response — day 7, dose 3, dependentMedDRA: Cough, Rhinorrhoea, Sneezing — Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Runny nose, sneezing, coughMedDRA releases: 2024-11 · check-in free text available
- 2021-12-24
- 2021-12-30
- 2022-01-06
- 2022-01-13
- 2022-01-20
- 2022-03-10
- 2022-06-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-17 | Moderna | No |
| 2 | 2021-04-14 | Moderna | No |
| 3 | 2021-12-09 | Moderna | No |
Free text
Release 10 — day 7, dose 3, dependent
Systemic reaction (other): Runny nose, sneezing, cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Cough | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
| SRO | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release